Infections caused by the Hepatitis C virus (HCV) affect around 70 million people worldwide,
leading to serious liver problems, such as fibrosis, steatosis, and cirrhosis, in addition to …

Sofosbuvir and Daclatasvir are among the direct‐acting antiviral (DAA) medications
prescribed for the treatment of chronic hepatitis C (CHC) virus infection as combination …

Background: Sofosbuvir (SOF) is a hopeful remedy for chronic hepatitis C virus infection.
However, it records some unfavorable influences on gastrointestinal tract. Fucoidan is a …

BACKGROUND: Sofosbuvir (SOF) was approved in 2013 as a part of first-line treatment for
hepatitis C virus (HCV); it has activity against all genotypes with extrahepatic adverse effects …

Yu Jun Wong, et al. VIEKIRA PAK induced interstitial lung disease http://www. e-cmh. org
https://doi. org/10.3350/cmh. 2018.0017 polymerase chain reaction (PCR) were negative …

Objective: Current research work was planned to investigate the medication-related side
effects and cytotoxic and bone marrow suppressive effects of DAAs to provide …

Background: Sofosbuvir (SOF) was published in 2013 as a part of first-line treatment for
Hepatitis C Virus (HCV) by The American Association for the Study of Liver Diseases. SOF …

Background: In the first stage of labor, the attitude of the fetal head (relationship of the fetal
head to the spine) may have a significant effect on the outcome of labor. Traditionally …

Background: Egypt has one of the highest hepatitis C virus (HCV) prevalence rates in the
world, which led the government to strive to control it. The national guidelines for chronic …